Oxford Biomedica Share News (OXB)

1 May 2013

Shares in Oxford BioMedica rise 15 percent after the gene-based biopharmaceutical specialist signs a deal to make clinical grade material for Novartis...

1 May 2013

Pharmaceutical giant Novartis has signed up biotech firm Oxford Biomedica to provide its gene delivery technology for a programme targeting various fo...

1 May 2013

The FTSE Small Cap index sheds 0.1 percent in early deals, underperforming its larger peers with the FTSE 100 up 0.4 percent and the FTSE 250 rising 0...

27 Feb 2013

Gene-based biopharmaceutical company Oxford BioMedica has reported that revenue rose to 7.8m pounds in the full year 2012 from 7.7m pounds one year ea...

10 Oct 2012

Oxford BioMedica, a gene-based biopharmaceutical company, has made a strategic decision to close the US trial of its TroVax product on patients with p...

31 Aug 2012

Brady, a provider of trading, risk management and settlement solutions to the energy, metals and commodities sectors, has said that it is in a payment...

8 Aug 2012

eXpansys, the online electronics retailer has delivered a 33 per cent increase in turnover in the 12 months to the end of April. Total revenues for th...

8 Jun 2012

Quadrise Fuels International, an emulsion fuels supplier, has admitted that during its first sea-borne assessment on a Mærsk container ship it was not...